Literature DB >> 27227291

Mechanisms of Antibiotic Resistance.

Jose M Munita1,2,3, Cesar A Arias1,2,4.   

Abstract

Emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide. Multidrug-resistant organisms have not only emerged in the hospital environment but are now often identified in community settings, suggesting that reservoirs of antibiotic-resistant bacteria are present outside the hospital. The bacterial response to the antibiotic "attack" is the prime example of bacterial adaptation and the pinnacle of evolution. "Survival of the fittest" is a consequence of an immense genetic plasticity of bacterial pathogens that trigger specific responses that result in mutational adaptations, acquisition of genetic material, or alteration of gene expression producing resistance to virtually all antibiotics currently available in clinical practice. Therefore, understanding the biochemical and genetic basis of resistance is of paramount importance to design strategies to curtail the emergence and spread of resistance and to devise innovative therapeutic approaches against multidrug-resistant organisms. In this chapter, we will describe in detail the major mechanisms of antibiotic resistance encountered in clinical practice, providing specific examples in relevant bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27227291      PMCID: PMC4888801          DOI: 10.1128/microbiolspec.VMBF-0016-2015

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  101 in total

Review 1.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 2.  MRSA: the first half century.

Authors:  Robert C Moellering
Journal:  J Antimicrob Chemother       Date:  2011-10-18       Impact factor: 5.790

3.  Antibiotics: vancomycin sensing.

Authors:  Michel Arthur
Journal:  Nat Chem Biol       Date:  2010-05       Impact factor: 15.040

4.  ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli.

Authors:  Laurent Poirel; Marie-Frédérique Lartigue; Jean-Winoc Decousser; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

6.  Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities.

Authors:  Luca Guardabassi; Yvonne Agersø
Journal:  FEMS Microbiol Lett       Date:  2006-06       Impact factor: 2.742

Review 7.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

Review 8.  Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

9.  In-depth profiling of the LiaR response of Bacillus subtilis.

Authors:  Diana Wolf; Falk Kalamorz; Tina Wecke; Anna Juszczak; Ulrike Mäder; Georg Homuth; Sina Jordan; Janine Kirstein; Michael Hoppert; Birgit Voigt; Michael Hecker; Thorsten Mascher
Journal:  J Bacteriol       Date:  2010-07-16       Impact factor: 3.490

Review 10.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

View more
  342 in total

1.  RNase I Modulates Escherichia coli Motility, Metabolism, and Resistance.

Authors:  Yashasvika Duggal; Benjamin M Fontaine; Deanna M Dailey; Gang Ning; Emily E Weinert
Journal:  ACS Chem Biol       Date:  2020-07-02       Impact factor: 5.100

2.  Community-acquired serious bacterial infections in the first 90 days of life: a revisit in the era of multi-drug-resistant organisms.

Authors:  Dawood Yusef; Tamara Jahmani; Sajeda Kailani; Rawan Al-Rawi; Wasim Khasawneh; Miral Almomani
Journal:  World J Pediatr       Date:  2019-06-22       Impact factor: 2.764

3.  Pandemic fluoroquinolone resistant Escherichia coli clone ST1193 emerged via simultaneous homologous recombinations in 11 gene loci.

Authors:  Veronika Tchesnokova; Matthew Radey; Sujay Chattopadhyay; Lydia Larson; Jamie Lee Weaver; Dagmara Kisiela; Evgeni V Sokurenko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

Review 4.  Identifying and Addressing Individuals Resistant to Behavioral Lifestyle Treatment.

Authors:  Katherine R Arlinghaus; Craig A Johnston
Journal:  Am J Lifestyle Med       Date:  2019-04-21

5.  Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues.

Authors:  Takashi Misawa; Chihiro Goto; Norihito Shibata; Motoharu Hirano; Yutaka Kikuchi; Mikihiko Naito; Yosuke Demizu
Journal:  Medchemcomm       Date:  2019-04-04       Impact factor: 3.597

6.  Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations.

Authors:  Sergey V Melnikov; David L Stevens; Xian Fu; Hui Si Kwok; Jin-Tao Zhang; Yue Shen; Jeffery Sabina; Kevin Lee; Harry Lee; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-13       Impact factor: 11.205

7.  Molecular Insights into Antimicrobial Resistance Traits of Commensal Human Gut Microbiota.

Authors:  Satyabrata Bag; Tarini Shankar Ghosh; Sayantan Banerjee; Ojasvi Mehta; Jyoti Verma; Mayanka Dayal; Anbumani Desigamani; Pawan Kumar; Bipasa Saha; Saurabh Kedia; Vineet Ahuja; Thandavarayan Ramamurthy; Bhabatosh Das
Journal:  Microb Ecol       Date:  2018-07-16       Impact factor: 4.552

8.  Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.

Authors:  Kwaku Kyei-Baffour; Haroon Mohammad; Mohamed N Seleem; Mingji Dai
Journal:  Bioorg Med Chem       Date:  2019-03-19       Impact factor: 3.641

9.  Ampicillin permeation across OmpF, the major outer-membrane channel in Escherichia coli.

Authors:  Ishan Ghai; Harsha Bajaj; Jayesh Arun Bafna; Hussein Ali El Damrany Hussein; Mathias Winterhalter; Richard Wagner
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

10.  Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.

Authors:  Tao Xiao; Ke Liu; Robert W Huigens
Journal:  Bioorg Med Chem Lett       Date:  2020-08-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.